Navigation Links
XTENT Announces European Regulatory Update
Date:6/12/2008

t at one or more locations. The Custom NX DES System has not been approved for sale by any regulatory authority.

About XTENT

XTENT, Inc. is a medical device company focused on developing and commercializing innovative customizable drug eluting stent (DES) systems for the treatment of coronary artery disease (CAD). CAD is the most common form of cardiovascular disease and the number one cause of death in the United States and Europe. XTENT(R) Custom NX(R) DES Systems are designed to enable the treatment of single lesions, long lesions and multiple lesions of varying lengths and diameters, in one or more arteries with a single device.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Statements in this press release regarding XTENT's business that are not historical facts may be "forward-looking statements" that involve risks and uncertainties. Specifically, these statements include, but are not limited to those concerning: XTENT's expectations with respect to the timing or results of its regulatory filings, the timing of responses to its regulatory filings and the timing of the commercialization of its products. Forward-looking statements are based on management's current, preliminary expectations, and are subject to risks and uncertainties that could cause actual results to differ from the results predicted and which are included in the "Risk Factors" section of XTENT's quarterly report on Form 10-Q for the quarter ended March 31, 2008. This quarterly report was filed with the SEC on May 13, 2008, and is available on the company's investor relations website at http://www.xtentinc.com and on the SEC's website at http://www.sec.gov. Undue reliance should not be placed on forward-looking statements, which speak only as of the date th
'/>"/>

SOURCE XTENT, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
2. XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
3. XTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week
4. XTENT Announces First Quarter 2008 Financial Results
5. Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis
6. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
7. XTENT to Present CUSTOM I and CUSTOM II Trial Data at TCT 2007
8. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
9. Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder
10. Cardiogenesis Announces Preliminary Clinical Results With the PHOENIX System Combining TMR + Stem Cells
11. Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... LONDON , Sept. 2, 2015 ... coil is used to treat an unruptured and ... artery wall). The treatment is either known as ... procedure, the endovascular coil blocks the blood flow ... usually performed under general anaesthesia by an interventional ...
(Date:9/2/2015)... 2015 Advanced Wound Dressings - 5EU ... dressings have steadily replaced traditional bandages and gauze ... wound indications, such as trauma wounds, burns, and ... physical protection become increasingly critical in wound healing, ... therapy. This report focuses on nine market ...
(Date:9/2/2015)... NEW YORK , Sept. 2, 2015   ... of the most common laboratory technologies that is used ... and antibodies in solution. ELISA test uses various types ... alkaline phosphatases and the result is detected by photometry ... in the treatment of various infectious diseases such as ...
Breaking Medicine Technology:Global Neuroendovascular Coil Market 2015-2019 2Advanced Wound Dressings - 5EU Analysis and Market Forecasts 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 3
... May 3, 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... 2011. For the first quarter of 2011, Rigel reported ... to a net loss of $22.3 million, or $0.43 per share, ... the first quarter of 2011 and 2010 were 52.3 million and ...
... Therapeutics, Inc. (Nasdaq: NLTX ), a biopharmaceutical ... today announced dosing of the first patient in a ... cenderitide.  The trial is being conducted pursuant to Nile,s ... clinical step towards developing cenderitide as a treatment for ...
Cached Medicine Technology:Rigel Announces First Quarter Financial Results 2Rigel Announces First Quarter Financial Results 3Rigel Announces First Quarter Financial Results 4Nile Therapeutics Announces Dosing of First Patient in Phase I Study of Cenderitide 2Nile Therapeutics Announces Dosing of First Patient in Phase I Study of Cenderitide 3
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... their team will be participating at the highly anticipated Mississippi Gulf Babypalooza on ... mothers coming from all over, from Gulfport, Biloxi, and beyond. We will be ...
(Date:9/3/2015)... ... September 03, 2015 , ... When looking at the types of people who have ... of two categories: those that have a weak appetite or those that have a fast ... to gain weight, CB-1 Weight Gainer gives three tips for slowing down metabolism. , The ...
(Date:9/3/2015)... ... ... Earl Jones will be hosting an upcoming VOICES IN AMERICA segment that highlights the ... that discusses why it is important for the workplace to be healthier, the effects ... environment. , Employers are out billions of dollars year after year due to sick ...
(Date:9/3/2015)... ... 2015 , ... The partnership will leverage Fidson’s strong and ... to promote LodonalTM in Nigeria. The distribution will become effective, upon completion of ... the product. , Managing Director, Fidson Healthcare Plc, Dr Fidelis Ayebae, expressed that ...
(Date:9/2/2015)... ... September 03, 2015 , ... ... listed among the most influential leaders in healthcare, will offer the keynote address ... take place October 15-16, 2015, in Palm Harbor, Florida, at the Innisbrook Resort ...
Breaking Medicine News(10 mins):Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 3Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:Fidson Partners US Firms on New Product Marketing 2Health News:Fidson Partners US Firms on New Product Marketing 3Health News:Fidson Partners US Firms on New Product Marketing 4Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3
... ... information on sexual health and sexual medicine easily accessible to the public and to ... TWSHF board of directors voted to dissolve the non-profit and donate its assets to ... ...
... , , , ... scientist M. Elizabeth "Betz" Halloran, M.D., M.P.H., D.S.c., has been awarded ... honor bestowed upon members of the American Association for the Advancement ... researcher in the Hutchinson Center,s Vaccine and Infectious Disease Institute and ...
... , LOS ANGELES, Dec. 17 ... and Energy-X lip balms, today announced the launch of ... heating/cooling treatment packs are specifically designed to reduce swelling ... variety of applications. Researchers behind Thermal-Aid created a line ...
... , Charmaine Yoest Urges "Comprehensive Respect for Life" in ... , WASHINGTON, Dec. 17 Americans United for Life Action President, ... Harry Reid as he considers a manager,s amendment - the Majority ... bill. The letter urges Senator Reid to include "specific language that ...
... from physician, study finds , THURSDAY, Dec. 17 (HealthDay News) ... parents to place infants on their backs to go to ... SIDS, researchers have found. , Since the U.S. government launched ... infants placed on their backs at sleep time has increased ...
... fall down on prevention, experts say , THURSDAY, Dec. ... getting better at treating heart attacks and other cardiovascular ... for preventing them, according to new statistics from the ... exercise, too much weight. , In fact, 59 percent ...
Cached Medicine News:Health News:The Women's Sexual Health Foundation to Transfer Assets to the National Vulvodynia Association 2Health News:The Women's Sexual Health Foundation to Transfer Assets to the National Vulvodynia Association 3Health News:M. Elizabeth Halloran Named AAAS Fellow 2Health News:M. Elizabeth Halloran Named AAAS Fellow 3Health News:M. Elizabeth Halloran Named AAAS Fellow 4Health News:Thermal-Aid Bears Provide Warm Comfort to Children at Penny Lane for the Holidays 2Health News:Pro-Life Leader Sends Urgent Letter to Senator Reid 2Health News:Doctor's Orders Influence Baby's Sleep Position 2Health News:Obesity, Inactivity Keeping Heart Health Stats Down 2Health News:Obesity, Inactivity Keeping Heart Health Stats Down 3
The Perfecta PDA components provide the design and material choice imperative in today's cost conscious medical climate....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Severe revision options for the knee and hip...
Medicine Products: